BIO pushes back on '60 Minutes report' on cancer drug costs, shifts blame to insurers

The Biotechnology Industry Organization pushed back Monday against a "60 Minutes" segment that attacked the high price of cancer drugs, instead shifting blame for outsized out-of-pocket costs to the insurance industry...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.